Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 408

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 408
---
 |     | DIV  |     |             |     |        19205420.3 |     |            |     |                   |     |        3626262 |     | 16/06/2036 |     | under examination |
| IN      |     | PCT  |     | 16/06/2016  |     |      201717043556 |     | 08.11.2023 |     |            467201 |     | 201717043556 A |     | 16/06/2036 |     | granted           |
| JP      |     | PCT  |     | 16/06/2016  |     |       2017-565248 |     | 21.09.2021 |     |     JP2017565248A |     |     2018517419 |     | 16/06/2036 |     | under examination |

250

| Country 
 Code    |     | Type |     | Filing date |     | Filing no. |     | Grant Date |     |  Grant no. |     | Publ. No.       |     | Expiry     |     | Status  |
| US      |     | PCT  |     | 16/06/2016  |     | 15/737,659 |     | 02/02/2021 |     | 10,905,752 |     | US 2018/0250345 |     | 16/06/2036 |     | granted |
| US      |     | CON  |     | 16/06/2016  |     | 17/107,203 |     |            |     |            |     | US20210077605A1 |     | 16/06/2036 |     | pending |
| ZA      |     | PCT  |     | 16/06/2016  |     | 2017/08439 |     | 26/05/2021 |     | 2017/08439 |     |                 |     | 16/06/2036 |     | granted |

VXM01 Tumor expression (7)
WO 2018/149982, Novel VEGFR-2 targeting immunotherapy approach

| Country 
 Code    |     | Type |     | Filing date |     |        Filing no. |     | Grant